BMI View: Jordan offers an attractive pharmaceutical market for multinational drugmakers, although its
potential will remain impeded by the ongoing political and economic instability in neighbouring Syria –
which is having a detrimental impact on Jordan’s healthcare sector.
Headline Expenditure Projections
? Pharmaceuticals: JOD643mn (USD905mn) in 2014 to JOD683mn (USD962mn) in 2015; +6.3% in
local currency terms and US dollar terms. Forecast unchanged from Q415.
? Healthcare: JOD1.86bn (USD2.62bn) in 2014 to JOD1.97bn (USD2.78bn) in 2015; +6.2% in local
currency terms and US dollar terms. Forecast in line with Q415.

Table of Contents

BMI Industry View 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Jordan 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Jordan 2011-2019) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Jordan 2011-2019) 14
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Jordan 2011-2019) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Jordan 2011-2019) 15
Prescription Drug Forecast 16
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Jordan 2011-2019) 17
Patented Drug Market Forecast 18
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Jordan 2011-2019) 19
Generic Drug Market Forecast 20
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Jordan 2011-2019) 21
OTC Medicine Market Forecast 22
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Jordan 2011-2019) 23
Pharmaceutical Trade Forecast 24
Table: Pharmaceutical Trade Data And Forecasts (Jordan 2013-2019) 26
Table: Pharmaceutical Trade Data And Forecasts local currency (Jordan 2013-2019) 26
Industry Risk/Reward Index 27
Middle East and Africa Risk/Reward Index - Q1 2016 27
Jordan Risk/Reward Index 35
Rewards 35
Risks 35
Regulatory Review 37
Regulatory Developments 38
Intellectual Property Issues 39
Pricing And Reimbursement Regime 42
Market Overview 46
Healthcare Sector 47
Healthcare Insurance 49
Table: Healthcare Resources (Jordan 2009-2014) 54
Table: Healthcare Personnel (Jordan 2009-2014) 54
Table: Healthcare Activity (Jordan 2009-2014) 55
Research & Development 55
Clinical Trials 57
Epidemiology 59
Competitive Landscape 61
Research-Based Industry 61
Table: Multinational Company Activity 64
Pharmaceutical Distribution 65
Pharmaceutical Retail Sector 66
Company Profile 68
Dar al-Dawa 68
Hikma Pharmaceuticals 71
Jordanian Pharmaceutical Manufacturing Company (JPM) 77
Pharma International Company 80
United Pharmaceutical Manufacturers 83
Demographic Forecast 86
Jordan Demographic Forecast 86
Table: Population Headline Indicators (Jordan 1990-2025) 87
Table: Key Population Ratios (Jordan 1990-2025) 87
Table: Urban/Rural Population & Life Expectancy (Jordan 1990-2025) 88
Table: Population By Age Group (Jordan 1990-2025) 88
Table: Population By Age Group % (Jordan 1990-2025) 89
Glossary 91
Methodology 93
Pharmaceutical Expenditure Forecast Model 93
Healthcare Expenditure Forecast Model 93
Notes On Methodology 94
Risk/Reward Index Methodology 95
Index Overview 96
Table: Pharmaceutical Risk/Reward Index Indicators 96
Indicator Weightings 97

List of Tables

Table: Headline Pharmaceuticals & Healthcare Forecasts (Jordan 2013-2019)
Table: Pharmaceutical Sales, Historical Data And Forecasts (Jordan 2011-2019)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Jordan 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Jordan 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Jordan 2011-2019)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Jordan 2011-2019)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Jordan 2011-2019)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Jordan 2011-2019)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Jordan 2011-2019)
Table: Pharmaceutical Trade Data And Forecasts (Jordan 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Jordan 2013-2019)
Table: Healthcare Resources (Jordan 2009-2014)
Table: Healthcare Personnel (Jordan 2009-2014)
Table: Healthcare Activity (Jordan 2009-2014)
Table: Multinational Company Activity
Table: Population Headline Indicators (Jordan 1990-2025)
Table: Key Population Ratios (Jordan 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Jordan 1990-2025)
Table: Population By Age Group (Jordan 1990-2025)
Table: Population By Age Group % (Jordan 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators